Lutathera for neuroendocrine tumours
Published on 20 April 2020
Lutathera therapy treatment for neuroendocrine tumours (NETs) is provided at the Beatson West of Scotland Cancer Centre in Glasgow.
What is the Lutathera Therapy Service?
The service provides in-patient and follow-up treatment to people with small bowel NETs that are somatostatin receptor (SSR) positive. Lutathera therapy slows down the growth of tumours, or prevents them from growing altogether.
After each treatment, a post-therapy nuclear medicine scan assesses distribution of the Lutathera. Follow-up care will continue to be provided jointly by the patient’s local team and the national service.
Professor Nick Reed, Consultant Clinical Oncologist, NHS Greater Glasgow & Clyde
Programme Manager, Karen Roberts – email@example.com – 0131 2756757
Beatson West of Scotland Cancer Centre
1053 Great Western Road